IUC26691-89

Abstract Code: IUC26691-89   Real-World Outcomes of Delayed Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Following Systemic Therapy: A Tertiary Centre Experience Hassan 1 , H. Warren 1 , R. Nair 1 , D. Crawley 1 , A. Khan 1 , A. Fernando 1 , T. O...

IUC26690-88

Abstract Code: IUC26690-88   Cannabinoid Receptor Profiling Reveals a Low CB1 and High CB2 signature in Clear Cell Renal Cell Carcinoma Singh 1, S. Pattanaik 2, R.S. Mavuduru 2, N. Kakkar 2, G.S. Bora 2 (1) PhD, Post-Graduate Institute of Medical Education and...

IUC26686-93

Abstract Code: IUC26686-93   Synergistic potential of cabozantinib and radiotherapy in advanced renal cell carcinoma by site of irradiation Di Costanzo 1, A. Bertocchi 2, M.L. Esposito 3, I.S. Parisi 4, A. Federico 2, P.A. Zucali 2, L. Formisano 3, C. Oing 1, R....

IUC26684-91

Abstract Code: IUC26684-91   Real world outcomes of immune checkpoint inhibitors in metastatic renal cell cancer(mRCC) from a tertiary care cancer centre in South India M.S. Chandrasekaran 1, P. Thamaraiselvan 1, A. Raja 1, V. Radhakrishnan 1 (1) Cancer Institute...

IUC26682-89

Abstract Code: IUC26682-89   Efficacy and tolerability of immune checkpoint inhibitors in older versus younger patients with metastatic renal cell carcinoma: a real-world Asian cohort Kanesvaran 1, H.S. Tan 1, J.W.K. Chan 1, W.C. Tan 1, D.J.M. Ang 1, J.J.X. Tan...

IUC26678-94

Abstract Code: IUC26678-94   Impact of Metastatic Patterns on First-Line Therapy in mRCC: Meet-URO 33 Peretto 1, S.E. Rebuzzi 2, E. Verzoni 3, S. Buti 4, M. Di Napoli 5, C. Lolli 6, M. Fanelli 7, C. Masini 8, P.A. Zucali 9, A. Mennitto 10, M. Sorarù 11, R....
error: Content is protected !!